MC Oberstadt, S Bien-Möller, K Weitmann, S Herzog… - BMC cancer, 2013 - Springer
Background Resistance of the highly aggressive glioblastoma multiforme (GBM) to drug
therapy is a major clinical problem resulting in a poor patient's prognosis. Beside promoter …